XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS) (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Total revenue, net $ 370,232 $ 379,095 $ 983,221 $ 1,122,430
Costs and expenses:        
Cost of goods sold 134,811 142,636 373,765 415,219
Research and development 19,460 19,003 55,202 54,957
In-process research and development 0 59,889 0 59,889
Selling, general and administrative 150,076 173,098 432,136 513,345
Intangible asset amortization 8,343 5,056 23,393 21,340
Total costs and expenses 312,690 399,682 884,496 1,064,750
Operating income (loss) 57,542 (20,587) 98,725 57,680
Interest income 2,273 2,913 7,124 8,051
Interest expense (20,796) (13,962) (54,230) (40,495)
Other income, net 2,492 4,127 2,985 8,461
Income (loss) before income taxes 41,511 (27,509) 54,604 33,697
Provision (benefit) for income taxes 9,174 101 13,456 (1,185)
Net income (loss) $ 32,337 $ (27,610) $ 41,148 $ 34,882
Net income (loss) per share        
Basic (in dollars per share) $ 0.38 $ (0.32) $ 0.49 $ 0.41
Diluted (in dollars per share) $ 0.38 $ (0.32) $ 0.48 $ 0.40
Weighted average common shares outstanding (See Note 14):        
Basic (in shares) 84,325 85,688 84,745 85,536
Diluted (in shares) 84,752 85,688 85,303 86,581
Comprehensive income (loss) (See Note 15) $ 43,548 $ (46,521) $ 25,637 $ (7,288)